Zobrazeno 1 - 5
of 5
pro vyhledávání: '"David X Sun"'
Autor:
Ahmet Dogan, Ryan A. Wilcox, Andrew L. Feldman, Stephen M. Ansell, Anne J. Novak, David X. Sun
Inhibition of Syk protein tyrosine kinase induces apoptosis and blocks proliferation in T-cell non-Hodgkin's lymphoma cell lines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddc4686b71d983ba670543e02212c562
https://europepmc.org/articles/PMC3122132/
https://europepmc.org/articles/PMC3122132/
Autor:
Bolette L. Caron, Ellen D. Remstein, Erik C. Thorland, Mark E. Law, William R. Macon, Ahmet Dogan, David X. Sun, Andrew L. Feldman, Ayoma D. Attygalle, Paul J. Kurtin, Stephanie R. Fink, Karen L. Grogg, William G. Morice, Anne J. Novak, Julie A. Vrana
Peripheral T-cell lymphomas (PTCLs) are fatal in the majority of patients and novel treatments, such as protein tyrosine kinase (PTK) inhibition, are needed. The recent finding of SYK/ITK translocations in rare PTCLs led us to examine the expression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28c3ad390fc6e94cd9eddafce19aee9e
https://europepmc.org/articles/PMC2778211/
https://europepmc.org/articles/PMC2778211/
Publikováno v:
Anesthesiology. 101(3)
Background Depression of myocardial contractility as a result of isoflurane appears to be greater in myocardial hypertrophy, and the cellular basis for this difference in susceptibility is not clear. In this study we examined the effects of isofluran
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e65f3e8ab7fa1eda8139e337907bbc6
https://pubmed.ncbi.nlm.nih.gov/15329592
https://pubmed.ncbi.nlm.nih.gov/15329592
Autor:
Shu-Hui Chen, David X Sun, Beverly A. Heinz, Yip Yvonne Yee Mai, Lifei Liu, Alexander A. Kolykhalov, Jason Eric Lamar, Q. May Wang, Robert B. Johnson
Publikováno v:
Bioorganicmedicinal chemistry letters. 14(16)
We describe herein the design, syntheses, and biological evaluation of new series of P4 tetrazole and adipic acid, ester, amide capped tetrapeptidyl alpha-ketoamide based HCV protease inhibitors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c26f66135fef5b6e9da403595e63aa9
https://pubmed.ncbi.nlm.nih.gov/15261297
https://pubmed.ncbi.nlm.nih.gov/15261297
Autor:
Paul J. Kurtin, Ahmet Dogan, Stephanie R. Fink, David X. Sun, Ellen D. Remstein, Julie A. Vrana, Anne J. Novak, William G. Morice, William R. Macon, Ayoma D. Attygalle, Erik C. Thorland, B. Lynn Caron, Mark E. Law, Andrew L. Feldman, Karen L. Grogg
Publikováno v:
Blood. 110:690-690
Peripheral T- and NK-cell lymphomas (PTCLs) are fatal in the majority of patients, and conventional chemotherapy is minimally effective. Targeted inhibition of tyrosine kinases (TKs) might be a useful treatment strategy, but TK overexpression by PTCL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d117b12f0e9f77e3bf62d873d3030f33
https://doi.org/10.1182/blood.v110.11.690.690
https://doi.org/10.1182/blood.v110.11.690.690